Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Lisdexamfetamine, sold under the brand names Vyvanse (/ˈvaɪ.væns/, VY-vans) and Elvanse among others, is a stimulant medication that is used as a treatment for attention deficit hyperactivity disorder (ADHD) in both children and adults, and for moderate-to-severe binge eating disorder in adults. A prodrug of dextroamphetamine, lisdexamfetamine is taken…
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Lisdexamfetamine.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Lisdexamfetamine shows recurring relationship patterns in the source. For example, Lisdexamfetamine → ADHD, Amphetamine, Australian Therapeutic Goods Administration, Concerta, Drug Administration, European, However, In, It, MAOI, OROSTooltip, Pharmaceutical, Prescribing, United States Food, USFDA Another extracted example is Lisdexamfetamine → ADHD, Drug Administration, FDA, Health Canada, In August, In February, It, New River Pharmaceuticals, NRP104, Robert Oberlender, Shire Pharmaceuticals, Takeda Pharmaceuticals, US Food. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
amphetamine dextroamphetamine adhd treatment use effects stimulant may disorder eating narcolepsy depression effective therapeutic used ph drug binge release trials
TTTA extracted 146 structured relationships around Lisdexamfetamine. Examples in this analysis include Lisdexamfetamine → 3D model (JSmol) → Interactive image and Lisdexamfetamine → Addiction liability → Moderate. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Lisdexamfetamine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Lisdexamfetamine | Addiction liability | Moderate | 1.00 | infobox |
| Lisdexamfetamine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Lisdexamfetamine | ATC code | N06BA12 (WHO) | 1.00 | infobox |
| Lisdexamfetamine | Bioavailability | Oral: 96.4% | 1.00 | infobox |
| Lisdexamfetamine | Boiling point | Not applicable; decomposes before boiling | 1.00 | infobox |
| Lisdexamfetamine | CAS Number | 608137-32-2 Y[IUPHAR] | 1.00 | infobox |
| Lisdexamfetamine | ChEMBL | ChEMBL1201222 Y | 1.00 | infobox |
| Lisdexamfetamine | ChemSpider | 9772458 Y | 1.00 | infobox |
| Lisdexamfetamine | Chirality | Dextrorotatory enantiomer | 1.00 | infobox |
| Lisdexamfetamine | CompTox Dashboard (EPA) | DTXSID00209652 | 1.00 | infobox |
| Lisdexamfetamine | Density | Not routinely reported for solid pharmaceutical salts | 1.00 | infobox |
| Lisdexamfetamine | Dependence liability | Physical: None Psychological: Moderate | 1.00 | infobox |
| Lisdexamfetamine | Drug class | Norepinephrine–dopamine releasing agent; Stimulant | 1.00 | infobox |
| Lisdexamfetamine | DrugBank | DB01255 Y | 1.00 | infobox |
| Lisdexamfetamine | Duration of action | 10–14 hours | 1.00 | infobox |
| Lisdexamfetamine | Elimination half-life | Lisdexamfetamine: <1 hour Dextroamphetamine: 10–12 h | 1.00 | infobox |
| Lisdexamfetamine | Excretion | Kidney: ~2% as Lisdexamfetamine and ~42% as Dextroamphetamine | 1.00 | infobox |
| Lisdexamfetamine | Formula | C15H25N3O | 1.00 | infobox |
| Lisdexamfetamine | IUPHAR/BPS | 7213 | 1.00 | infobox |
| Lisdexamfetamine | KEGG | D08130 | 1.00 | infobox |
| Lisdexamfetamine | KEGG | as salt: D04747 | 1.00 | infobox |
| Lisdexamfetamine | Legal status | AU: S8 (Controlled drug) | 1.00 | infobox |
| Lisdexamfetamine | Legal status | BR: Class A3 (Psychoactive drugs) | 1.00 | infobox |
| Lisdexamfetamine | Legal status | CA: Controlled Drug (CDSA I) | 1.00 | infobox |
| Lisdexamfetamine | Legal status | DE: Anlage III (Special prescription form required) | 1.00 | infobox |
| Lisdexamfetamine | Legal status | NZ: Class B | 1.00 | infobox |
| Lisdexamfetamine | Legal status | UK: Class B | 1.00 | infobox |
| Lisdexamfetamine | Legal status | US: Schedule II | 1.00 | infobox |
| Lisdexamfetamine | Legal status | EU: Rx-only | 1.00 | infobox |
The concept neighborhoods around Lisdexamfetamine bring nearby vocabulary together. In this analysis, examples include Dextroamphetamine, Treatment and Use. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Lisdexamfetamine, one of the stronger structural bridges in this analysis connects Lisdexamfetamine with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Lisdexamfetamine to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Lisdexamfetamine · EN edition · Analysis: TopicsToTalkAbout